INTRODUCTION: Medulloblastoma is the most frequent type of embryonal tumor in the pediatric population, accounting for 20-25% of all brain tumors in children. Recently, the suspected contribution of the Polycomb group (PcG) genes in medulloblastoma development was described. PcG genes play an important role in developmental processes; they are also involved in the self-renewal of hematopoietic and neural stem cells as well as in malignant transformation. PURPOSE: In this study, we evaluated the expression of BMI1and PCGF2, members of family of PcG genes, and their potential target, MYC oncogene, and analyzed their association with demographic and clinical data. MATERIALS AND METHODS: Thirty-one children (18 males and 13 females, aged from 0.4 to 17 years) with medulloblastoma were included in this study. The gene's expression level was measured by quantitative real-time PCR, obtained using the two-color multiplexing technique. RESULTS: We found that the higher expression levels of BMI1 and PCGF2 genes were associated with significantly decreased patient survival (p = 0.02 and p = 0.012, respectively). Significant differences between gender were found, with a higher expression level of the PCGF2 gene observed among females (p = 0.02). CONCLUSION: Our analysis showed correlation between BMI1 and PCGF2 gene's expression and survival in children with medulloblastoma.
INTRODUCTION:Medulloblastoma is the most frequent type of embryonal tumor in the pediatric population, accounting for 20-25% of all brain tumors in children. Recently, the suspected contribution of the Polycomb group (PcG) genes in medulloblastoma development was described. PcG genes play an important role in developmental processes; they are also involved in the self-renewal of hematopoietic and neural stem cells as well as in malignant transformation. PURPOSE: In this study, we evaluated the expression of BMI1and PCGF2, members of family of PcG genes, and their potential target, MYC oncogene, and analyzed their association with demographic and clinical data. MATERIALS AND METHODS: Thirty-one children (18 males and 13 females, aged from 0.4 to 17 years) with medulloblastoma were included in this study. The gene's expression level was measured by quantitative real-time PCR, obtained using the two-color multiplexing technique. RESULTS: We found that the higher expression levels of BMI1 and PCGF2 genes were associated with significantly decreased patient survival (p = 0.02 and p = 0.012, respectively). Significant differences between gender were found, with a higher expression level of the PCGF2 gene observed among females (p = 0.02). CONCLUSION: Our analysis showed correlation between BMI1 and PCGF2 gene's expression and survival in children with medulloblastoma.
Authors: J Herms; I Neidt; B Lüscher; A Sommer; P Schürmann; T Schröder; M Bergmann; B Wilken; S Probst-Cousin; P Hernáiz-Driever; J Behnke; F Hanefeld; T Pietsch; H A Kretzschmar Journal: Int J Cancer Date: 2000-09-20 Impact factor: 7.396
Authors: Prasenjit Das; Tarun Puri; Vaishali Suri; M C Sharma; B S Sharma; Chitra Sarkar Journal: Childs Nerv Syst Date: 2009-05-15 Impact factor: 1.475
Authors: Lowell Evan Michael; Bart A Westerman; Alexandre N Ermilov; Aiqin Wang; Jennifer Ferris; Jianhong Liu; Marleen Blom; David W Ellison; Maarten van Lohuizen; Andrzej A Dlugosz Journal: Neoplasia Date: 2008-12 Impact factor: 5.715
Authors: Matthias Becker; Christian Korn; Arnold R Sienerth; Robert Voswinckel; Katharina Luetkenhaus; Fatih Ceteci; Ulf R Rapp Journal: PLoS One Date: 2009-01-19 Impact factor: 3.240
Authors: Neha Kamran; Alexandra Calinescu; Marianela Candolfi; Mayuri Chandran; Yohei Mineharu; Antonela S Asad; Carl Koschmann; Felipe J Nunez; Pedro R Lowenstein; Maria G Castro Journal: Expert Opin Biol Ther Date: 2016-07-27 Impact factor: 4.388